Home > Insider Trading > Filing (0000899243-22-011518)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492422	Apellis Pharmaceuticals Inc.	APLS	Pharmaceutical Preparations (2834)	271537290

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1496687	Alec Machiels	C/O Apellis Pharmaceuticals, Inc. 100 Fifth Avenue, 3Rd Floor Waltham MA 02451		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-15	1,250	$2.67	260,794	No	4	M	Direct
Common Stock	Disposition	2022-03-15	1,250	$39.57	259,544	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to buy)	Disposition	2022-03-15	1,250	$0.00	1,250	$2.67

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
124,779		2023-12-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	250,000	Indirect	See footnote
Common Stock	11,950	Indirect	See footnote
Common Stock	150,000	Indirect	See footnote

Footnotes

The sale reported in this Form 4 where effected pursuant to a written Rule 10b5-1 trading plan adopted by the reported person.
The shares are held by Bauhaus 1 LLC, which LLC is held by The Irrevocable Agreement of Trust of Alec Machiels (the "Trust"). The reporting person is the managing member of Bauhaus 1 LLC and the trustee of the Trust.
Owned by the spouse of the reporting person.
Owned by a trust of which the reporting person is the trustee.
This option was granted on December 5, 2013 and is fully vested.